Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Outpatient subcutaneous alemtuzumab is feasible and safe for aplastic anemia and is associated with high response rates Blood Advances Aplastic Anemia
Venetoclax/FluBu2 RIC transplant followed by all-oral venetoclax/decitabine maintenance for poor-risk MDS/AML Blood Advances Myelodysplastic Syndromes (MDS)
Venetoclax and Hypomethylating Agents (HMAs) Induce High Response Rates in MDS, Including Patients After HMA Therapy Failure Blood Advances Myelodysplastic Syndromes (MDS)
Modified Delphi Panel Consensus Recommendations for Management of Severe Aplastic Anemia Blood Advances Aplastic Anemia
A phase 3 randomized study of 5-azacitidine maintenance vs observation after transplant in high-risk AML and MDS patients Blood Advances Myelodysplastic Syndromes (MDS)
Baseline and serial molecular profiling predicts outcomes with hypomethylating agents in myelodysplastic syndromes Blood Advances Myelodysplastic Syndromes (MDS)
SF3B1-mutant myelodysplastic syndrome as a distinct disease subtype - A Proposal of the International Working Group for the Prognosis of Myelodysplastic Syndromes (IWG-PM) Blood Myelodysplastic Syndromes (MDS)
The conundrum of drug development in higher-risk MDS: lessons learned from recently failed phase 3 clinical trials Blood Myelodysplastic Syndromes (MDS)
The landscape of disease: mapping aplastic anemia Blood Aplastic Anemia
The trajectory of prognostication and risk stratification for patients with myelodysplastic syndromes Blood Myelodysplastic Syndromes (MDS)

Website Feedback

Please use this feedback form to report website issues only. For other issues concerning patients and families, please email help@aamds.org or use the Patient and Family Helpline here.

We Recommend

For Research